1078 related articles for article (PubMed ID: 29501581)
1. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
2. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
3. Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling.
Hu Z; You P; Xiong S; Gao J; Tang Y; Ye X; Xia Y; Zhang D; Liu Y
Biomed Pharmacother; 2017 Nov; 95():11-17. PubMed ID: 28826091
[TBL] [Abstract][Full Text] [Related]
4. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
5. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
6. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
8. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
[TBL] [Abstract][Full Text] [Related]
9. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
10. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
12. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
13. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C
Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414
[TBL] [Abstract][Full Text] [Related]
14. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
[TBL] [Abstract][Full Text] [Related]
15. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways.
Shi L; Zhou L; Han M; Zhang Y; Zhang Y; Yuan XX; Lu HP; Wang Y; Yang XL; Liu C; Wang J; Liang P; Liu SA; Liu XJ; Cheng J; Lin SM
World J Gastroenterol; 2023 May; 29(18):2798-2817. PubMed ID: 37274069
[TBL] [Abstract][Full Text] [Related]
17. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
19. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
